Flash Posts

Fabtech Technologies share price Photo Credit: https://hdfcsky.com

Fabtech Technologies Share Price: Stock Market Today Sees Muted Debut After 2x Subscribed IPO

The highly anticipated listing of Fabtech Technologies Ltd made its debut on the stock market today, opening nearly flat despite strong demand during the IPO. Investors appeared cautious, keeping the trading activity subdued on both BSE and NSE.

Market Performance: Flat Listing After IPO

Fabtech Technologies share price debuted at Rs 191 per share on BSE, matching its IPO price. On the NSE, the stock listed slightly higher at Rs 192 per share, reflecting a minor 0.52% premium.

This muted start comes even though the IPO had been subscribed more than two times its offer size during the subscription period from September 29 to October 1.

Main News: IPO Response

The market debut highlights that while investor interest was strong during the IPO, the secondary market opened cautiously. The flat listing suggests a balanced approach from investors, waiting to see the stock’s movement before taking further positions.

Company Details: Fabtech Technologies IPO Overview

Fabtech Technologies, a turnkey engineering solutions provider for the pharmaceutical, biotech, and healthcare sectors, launched its first public issue in late September.

Key IPO details:

  • IPO Size: Rs 230 crore
  • Type: Fresh issue of equity shares
  • Number of Shares: 1.2 crore
  • Price Band: Rs 181 – Rs 191 per share

Use of IPO Proceeds:

  • Funding working capital requirements
  • Supporting inorganic growth initiatives through acquisitions
  • General corporate purposes

Despite strong subscription numbers, the stock opened flat in the market, reflecting measured investor sentiment on listing day.

Business Overview: Engineering Solutions for Pharma and Biotech

Fabtech Technologies delivers end-to-end solutions in the pharma engineering space. Its offerings cover:

  • Design and engineering of specialized pharmaceutical equipment
  • Procurement, installation, and testing
  • Serving a wide range of clients in the pharmaceutical, biotech, and healthcare industries

By June 2024, the company had successfully completed 35 projects across multiple countries including Saudi Arabia, Egypt, Algeria, Bangladesh, Ethiopia, Sri Lanka, and the UAE. This global footprint reinforces Fabtech’s position as a reliable partner for turnkey engineering projects.

Summary: Key Highlights

  • Listing Price on BSE: Rs 191
  • Listing Price on NSE: Rs 192 (+0.52% premium)
  • IPO Subscription: Over 2x its offer size
  • IPO Size: Rs 230 crore (fresh issue)
  • Company Focus: Turnkey engineering solutions for pharma, biotech, and healthcare

The listing shows a measured market response, with the stock opening flat despite the strong underlying demand during the IPO phase.

Unistone Capital acted as the sole book-running lead manager for the issue.

About Author

Bhumish Sheth

Bhumish Sheth is a writer for Qrius.com. He brings clarity and insight to topics in Technology, Culture, Science & Automobiles. His articles make complex ideas easy to understand. He focuses on practical insights readers can use in their daily lives.

what is qrius

Qrius reduces complexity. We explain the most important issues of our time, answering the question: “What does this mean for me?”

Featured articles